A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials-Reference-Cited by-同舟云学术

A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials

Published:2022-08-19 Issue:7 Volume:22 Page:1061-1070
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Nosrati Marzieh¹^ORCID,Nikfar Shekoufeh¹²^ORCID,Hasanzad Mandana²³

Affiliation:

1. Department of Pharmacoeconomics and pharmaceutical administration, Faculty of Pharmacy, Tehran university of medical sciences, Tehran, Iran

2. Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran university of medical sciences, Tehran, Iran

3. Medical Genomics Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2022.2108408

Reference84 articles.

1. A review of international coverage and pricing strategies for personalized medicine and orphan drugs

2. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology

3. Administration UFD. Master protocols: efficient clinical trial design strategies to expedite development of oncology drugs and biologics guidance for industry-DRAFT GUIDANCE. FDA Maryland. 2018

4. Conducting economic evaluation based on basket clinical trial in the area of precision medicine

5. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples